Dermatologic Surgery · 2005 · 51 citations · 6 references
MedicinePharmacologyPharmacotherapyClinical PharmacologyDosage Form DesignDrug DeliveryBotulinum Toxin TherapyBotulinum Toxin TreatmentTest Product ComparisonBotulinum NeurotoxinBotulinum Toxin DosageBotulinum ToxinsCosmetic UseDouble-blind TrialsGlabellar Lines TreatmentOptimal Dose SelectionPilot Study Design
BACKGROUND: Botulinum toxins have been proven effective for reducing facial lines. There are two commercial types of botulinum toxin type A available in many countries but no published comparison studies. OBJECTIVE: To compare the efficacy and tolerability of Botox Cosmetic and Dysport 50 U in the treatment of glabellar lines (using 20 U of Botox Cosmetic, which is the dose approved by the US Food and Drug Administration for the treatment of glabellar lines, and 50 U of Dysport, which has been reported to be the optimal dose for this formulation). STUDY DESIGN: Parallel-group double-blind pilot study. Evaluation by observing physician, photographic, and patient evaluations. CONCLUSION: Botox 20 U provided better and more prolonged efficacy than Dysport 50 U in the treatment of glabellar lines.
6
Jean Carruthers, Nicholas J. Lowe, Alan Menter et al. · Journal of the American Academy of Dermatology · 2002 · 429 citations
Benjamin Ascher, Benjamin Zakine, Philippe Kestemont et al. · Journal of the American Academy of Dermatology · 2004 · 183 citations
Effect of Botulinum Toxin A on Facial Wrinkle Lines in Koreans
Helen Lew, Young Soo Yun, Sang Yeul Lee et al. · Ophthalmologica · 2002 · 33 citations